These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 823107)

  • 1. Preparation of a purified antigenic cholera toxoid.
    Germanier R; Fürer E; Varallyay S; Inderbitzin TM
    Infect Immun; 1976 Jun; 13(6):1692-8. PubMed ID: 823107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigenicity of cholera toxoid in humans.
    Germanier R; Fürer E; Varallyay S; Inderbitzin TM
    J Infect Dis; 1977 Apr; 135(4):512-6. PubMed ID: 856918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a purified cholera toxoid. III. Refinements in purification of toxin and methods for the determination of residual somatic antigen.
    Rappaport RS; Pierzchala WA; Bonde G; McCann T; Rubin BA
    Infect Immun; 1976 Sep; 14(3):687-93. PubMed ID: 823117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against experimental cholera by oral or parenteral immunization.
    Peterson JW
    Infect Immun; 1979 Nov; 26(2):594-8. PubMed ID: 546789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the tissue receptors for Vibrio cholerae and Escherichia coli enterotoxins by means of gangliosides and natural cholera toxoid.
    Holmgren J
    Infect Immun; 1973 Dec; 8(6):851-9. PubMed ID: 4206342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A toxoid prepared from cholera toxin by iodination.
    Heneine IF; Lahmann WM; Rocha OA
    Braz J Med Biol Res; 1992; 25(9):913-7. PubMed ID: 1342838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The population composition of cultures of Vibrio cholerae strain 569 B Pakistan in relation to the manufacture of a cholera vaccine (choleragen-anatoxin+O-antigen)].
    Lobanov VV; Nechetskaia RM; Adamova GV
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Aug; (8):73-6. PubMed ID: 2461623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simple method for purifying choleragenoid, the natural toxoid of Vibrio cholerae.
    Mekalanos JJ; Collier RJ; Romig WR
    Infect Immun; 1977 Jun; 16(3):789-95. PubMed ID: 892899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Characteristics of the immunogenic properties of cholerogen-anatoxin according to gel precipitation reactions and quantity of reducing sugars].
    Dzhaparidze MN; Martens LA; Egorova VD; Karaeva LT; Derteva II
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Jun; (6):48-51. PubMed ID: 808056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a purified cholera toxoid. II. Preparation of a stable, antigenic toxoid by reaction of purified toxin with glutaraldehyde.
    Rappaport RS; Bonde G; McCann T; Rubin BA; Tint H
    Infect Immun; 1974 Feb; 9(2):304-17. PubMed ID: 4205946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholera toxin and toxoid.
    Ungar J; Stanić M; Chariatte N; Varallyay SJ
    Prog Immunobiol Stand; 1971; 5():348-9. PubMed ID: 4660540
    [No Abstract]   [Full Text] [Related]  

  • 12. Synergistic protection against experimental cholera by immunization with cholera toxoid and vaccine.
    Peterson JW
    Infect Immun; 1979 Nov; 26(2):528-33. PubMed ID: 546785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic protective effect in rabbits of immunization with Vibrio cholerae lipopolysaccharide and toxin/toxoid.
    Svennerholm AM; Holmgren J
    Infect Immun; 1976 Mar; 13(3):735-40. PubMed ID: 1270131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity and protective capacity of inactivated "vibrio cholerae" whole cell vaccines.
    Cryz SJ; Fürer E; Germanier R
    Dev Biol Stand; 1983; 53():67-72. PubMed ID: 6873478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental immunisation and protection of guinea pigs with Vibrio cholerae toxoid and mucinases, neuraminidase and proteinase.
    Stewart-Tull DE; Lucas C; Bleakley CR
    Vaccine; 2004 Jun; 22(17-18):2137-45. PubMed ID: 15149770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demonstration of shared and unique immunological determinants in enterotoxins from Vibrio cholerae and Escherichia coli.
    Clements JD; Finkelstein RA
    Infect Immun; 1978 Dec; 22(3):709-13. PubMed ID: 83301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proceedings: Interrelationships between cholera toxin, cholera toxoid, and cellular immunity.
    Northrup R; Sutton A; Craig J
    Jpn J Med Sci Biol; 1975 Feb; 28(1):79-81. PubMed ID: 808659
    [No Abstract]   [Full Text] [Related]  

  • 18. Experimental studies on cholera immunization. 4. The antibody response to formalinized Vibrio cholerae and purified endotoxin with special reference to protective capacity.
    Svennerholm AM
    Int Arch Allergy Appl Immunol; 1975; 49(4):434-52. PubMed ID: 808500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of reactions and serological response to cholera vaccines in a controlled field trial conducted in the USSR.
    Burgasov PN; Sumarokov AA; Lelikov VL; Marcuk LM; Fedenev VG; Dzaparidze MN; Karaeva LT; Derteva II
    Bull World Health Organ; 1976; 54(2):163-70. PubMed ID: 798636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subunit structure of cholera toxin.
    Lönnroth I; Holmgren J
    J Gen Microbiol; 1973 Jun; 76(2):417-27. PubMed ID: 4198716
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.